Arnold et al. reported a median time to neutrophil recovery of 13 days in pediatric patients with hematologic malignancies who received αβT/CD19 depleted HCT from unrelated donors following myeloablative conditioning with busulfan or total body irradiation, cyclophosphamide and thiotepa (50). This evidence concerns the gene CD19 and hematologic disorder.